We observed that the pulmonary environment of mild COVID-19 patients induced the upregulation of only five pro-inflammatory genes in MSCs, which code for the chemokines CCL5 and XCL2, plus TRAF1, which has already been identified as an important inflammatory mediator in the lungs (75). This evidence concerns the gene TRAF1 and COVID-19.